Picture of Bionime logo

4737 Bionime Share Price

0.000.00%
tw flag iconLast trade - 00:00
HealthcareConservativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+0.13%
3m-3.66%
6m-9.52%
1yr-12.59%
Volume Change (%)
10d/3m-38.56%
Price vs... (%)
52w High-23.64%
50d MA-0.42%
200d MA-6.09%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-0.28%
Return on Equity0.35%
Operating Margin-0.53%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueTWDm2,172.921,668.591,849.922,210.591,755.572,098n/a-2.64%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-38.3-42.9+39.21+6.19-93.35+1072.41n/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Bionime EPS forecast chart

Profile Summary

Bionime Corporation is a Taiwan-based company principally engaged in the manufacture and distribution of blood glucose monitoring products. The Company's main products include blood glucose monitoring devices and blood glucose testing chips. Its products are applied in the testing and monitoring of blood glucose density. The Company distributes its products mainly to overseas markets, including Europe, Asia, the Americas and others.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
April 14th, 2003
Public Since
August 26th, 2009
No. of Employees
671
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
tw flag iconTaiwan Stock Exchange
Shares in Issue
60,942,400

4737 Share Price Performance

Upcoming Events for 4737

Bionime Corp Annual Shareholders Meeting

Bionime Corp Annual Shareholders Meeting

Similar to 4737

Picture of Apex Biotechnology logo

Apex Biotechnology

tw flag iconTaiwan Stock Exchange

Picture of Wellell logo

Wellell

tw flag iconTaiwan Stock Exchange

Picture of CHC Healthcare logo

CHC Healthcare

tw flag iconTaiwan Stock Exchange

Picture of Excelsior Medical Co logo

Excelsior Medical Co

tw flag iconTaiwan Stock Exchange

Picture of Lead Data logo

Lead Data

tw flag iconTaiwan Stock Exchange

FAQ